Canadian flu diagnostic and treatment market is projected to grow at a CAGR of 3.67% throughout the forecast period. The declining number of individuals settling for the flu vaccine is prompting an ascent in influenza rate in Canada which, thus, is reinforcing the development of the canada flu diagnostic and treatment market. The rising aging populace is additionally adding to the market growth of this flu diagnostic and treatment market.